Impaired simultaneous cognitive task performance in parkinson's disease: A dopamine–related dysfunction

Neurology

Volumn 44, Issue 2, 1994, Pages 319-326

  Malapani, C ^a   Pillon, B ^a   Dubois, B ^a   Agid, Y ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE;

ADULT; AGED; ARTICLE; AUDITORY RESPONSE; COGNITION; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DOPAMINERGIC TRANSMISSION; FEMALE; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; SENSORIMOTOR FUNCTION; TASK PERFORMANCE; VISION;

ACOUSTIC STIMULATION; AGED; CHOICE BEHAVIOR; COGNITION; COLOR PERCEPTION; CORPUS STRIATUM; DOPAMINE; FEMALE; HUMAN; MALE; MIDDLE AGE; MOTOR ACTIVITY; PARKINSON DISEASE; PSYCHOMOTOR PERFORMANCE; REACTION TIME; REFERENCE VALUES;

EID: 0028209625     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.44.2.319     Document Type: Article

References (46)

1. Hallett M, Khoshbin S. A physiological mechanism of bradykinesia. Brain 1980;103:301-314.
2. Schwab RS, Chafetz ME, Walker S. Control of two simultaneous voluntary acts in normals and in parkinsonism. Arch Neurol 1954;72:591-598.
3. Talland GA, Schwab RS. Performance with multiple sets in Parkinson’s disease. Neuropsychologia 1964;2:45-53.
4. Benecke R, Rothwell JC, Dick JPR, Day BL, Marsden CD. Performance of simultaneous movements in patients with Parkinson’s disease. Brain 1986;109:739-757.
5. Rogers MW, Chan CWY. Motor planning is impaired in Parkinson’s disease. Brain Res 1988;438:271-276.
6. Marsden CD. What do the basal ganglia tell premotor cortical areas? In: Motor areas of the cerebral cortex. CIBA Foundation Symposium 132. Chichester, UK: Wiley, 1987:282300.
7. Rogers D. Bradyphrenia in Parkinson’s disease. In: Hubert SG, Cummings GL, eds. Parkinson’s disease-neurobehav- ioral aspects. New York: Oxford University Press, 1992:19 5240.
8. Bloxham CA, Dick DJ, Moore M. Reaction times and attention in Parkinson’s disease. J Neurol Neurosurg Psychiatry 1987;50:1178-1183.
9. Evarts EV, Teravainen H, Caine DB. Reaction time in Parkinson’s disease. Brain 1981;104:167-186.
10. Dubois B, Boiler F, Pillon B, Agid Y. Cognitive deficits in Parkinson’s disease. In: Boiler F, Grafman J, eds. Handbook of neuropsychology, vol 5. Amsterdam: Elsevier, 1991:195240.
11. Pillon B, Dubois B, Bonnet A-M, et al. Cognitive slowing in Parkinson’s disease fails to respond to levodopa treatment: the 15-objects test. Neurology 1989;39:762-768.
12. Brown RG, Marsden CD. Dual task performance and processing resources in normal subjects and patients with Parkinson’s disease. Brain 1991;114:215-231.
13. Taylor AE, Saint-Cyr JA, Lang AE. Frontal lobe dysfunction in Parkinson’s disease. Brain 1986;109:845-883.
14. Agid Y, Javoy-Agid F, Ruberg M. Biochemistry of neurotransmitters in Parkinson’s disease. In: Marsden CD, Fahn S, eds. Movement disorders, vol 2. London: Butterworths, 1987:166-230.
15. Benecke R, Rothwell JC, Dick JPR, Day BL, Marsden CD. Simple and complex movements off and on treatment in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 1987;50:296-303.
16. Pullman SL, Watts RL, Juncos JL, Chase TN, Sanes JN. Dopaminergic effects on simple and choice reaction time performance in Parkinson’s disease. Neurology 1988;38:249- 254.
17. Rafal RD, Posner MI, Walker JA, Friedrich FJ. Cognition and the basal ganglia. Brain 1984;107:1083-1094.
18. Hietanen M, Teravainen H. Cognitive performance in early Parkinson’s disease. Acta Neurol Scand 1986;73:151-159.
19. Mayeux R, Stern Y, Sano M, Cote L, Williams JBW. Clinical and biochemical correlates of bradyphrenia in Parkinson’s disease. Neurology 1987;37:1130-1134.
20. Dubois B, Pillon B, Legault F, Agid Y, Lhermitte F. Slowing of cognitive processing in progressive supranuclear palsy. A comparison with Parkinson’s disease. Arch Neurol 1988;45: 1194-1199.
21. Starkstein SE, Esteguy M, Berthier ML, Garcia H, Lei- guarda L. Evoked potentials, reaction time and cognitive performance in on and off phases of Parkinson’s disease. J Neurol Neurosurg Psychiatry 1989;52:338-340.
22. Zimmermann P, Sprengelmeyer R, Fimm B, Wallesch CW. Cognitive slowing in decision tasks in early and advanced Parkinson’s disease. Brain Cogn 1992;18:60-69.
23. Folstein MF, Folstein SE, McHugh PR. ‘Mini-mental state.’ A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
24. Montgomery SA, Asberg MA. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134: 382-389.
25. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-442.
26. Fahn S, Elton RL, and members of the UPDRS Development Committee. Unified Parkinson’s disease rating scale. In: Fahn S, Marsden CD, Goldstein M, Caine DB, eds. Recent developments in Parkinson’s disease, vol 2. Florham Park, NJ: Macmillan, 1987:153-163.
27. Esteguy M, Bonnet AM, Kefalos J, Lhermitte F, Agid Y. Le test a la L-dopa dans la maladie de Parkinson. Rev Neurol (Paris) 1985;141:413-415.
28. Nelson HE. A modified card sorting test sensitive to frontal lobe defect. Cortex 1976;12:313-324.
29. Benton AL. Differential behavioral effects in frontal lobe disease. Neuropsychologia 1968;6:53-60.
30. Luria AR. Higher cortical functions in man. New York: Basic Books, 1966.
31. Lhermitte F, Pillon B, Serdaru M. Human autonomy and the frontal lobes-I: imitation and utilization behaviors: a neuropsychological study of 75 patients. Ann Neurol 1986; 19:326-334.
32. Stroop GR. Studies of interference in serial verbal reactions. J Exp Psychol 1935;18:643-662.
33. Reitan RM. Validity of the Trail Making Test as an indication of organic brain damage. Percept Mot Skills 1958;8:271- 276.
34. Stern Y, Mayeux R, Cote L. Reaction time and vigilance in Parkinson’s disease: possible role of norepinephrine metabolism. Arch Neurol 1984;41:1086-1089.
35. Horstink MW, Berger HJ, Spaendonck KP, Van Den Bercken JH, Cools AR. Bimanual simultaneous motor performance and impaired ability to shift attention in Parkinson’s disease. J Neurol Neurosurg Psychiatry 1990;53:685- 690.
36. Botwinick J. Aging and behavior. New York: Springer, 1973: 154-180.
37. Carter MC, Shapiro DC. Control of sequential movements: evidence of generalized motor programs. J Neurophysiol 1984;52:787-797.
38. Stelmach GE, Worringham CJ. The control of bimanual aiming movements in Parkinson’s disease. J Neurol Neurosurg Psychiatry 1988;51:223-231.
39. Baddeley AD. Working memory, Oxford, UK: Oxford University Press, 1986.
40. Shallice T. Specific impairments of planning. Philos Trans R Soc Lond [Biol] 1982;298:199-209.
41. Olton DS, Wenk GL, Church RM, Meek WH. Attention and the frontal cortex as examined by simultaneous temporal processing. Neuropsychologia 1988;26:307-318.
42. Petrides M, Iversen S. The effect of selective anterior and posterior association cortex lesions in the monkey on performance of a visual-auditory compound discrimination test. Neuropsychologia 1978;16:527-537.
43. Alexander GE, Crutcher MD. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci 1990;13:266-273.
44. Gaspar P, Duyckaerts C, Alvarez C, Javoy-Agid F, Berger B. Alterations of dopaminergic and noradrenergic innervations in motor cortex in Parkinson’s disease. Ann Neurol 1991;31: 365-374.
45. Agid Y, Ruberg M, Dubois B, Pillon B. Anatomoclinical and biochemical concepts of subcortical dementia. In: Stahl FM, Iversen SD, Goodman EC, eds. Cognitive neurochemistry. Oxford, UK: Oxford University Press, 1987:248-271.
46. Tanji J, Okano K, Sato KC. Relation of neurons in the nonprimary motor cortex to bilateral hand movement. Nature 1987;32:618-620.